IRA C. SPECTOR. PhdCEO, CO-FOUNDER
PhD, University of Medicine & Dentistry, NJ (Rutgers), MBA,
Drexel University
Wyeth, Pfizer, Allergan, ICON;
experienced drug developer on 34 NDAs and co-founder of
4 prior startups, 30 years of experience
MARK FEITELSON, phdCSO, CO-FOUNDER
PhD, Immunovirology, UCLA Geffen Medical School;
Co-inventor, Professor at Temple University
World-class
expert in liver disease; advisor to Chiron Diagnostics,
Biogen, Immune Response Corp, Pharmasset &
amp; QuadPharma, Ribozyme, Maxygen, USINO, and Theravectys, 35 years of experience
ALLA ARZUMANYAN, PhdCDO, CO-FOUNDER
PhD, Biotechnology, Yerevan University, Armenia;
Co-inventor; Assistant Professor at Temple and
Jefferson University;
Expert in stem cell cancers,
HBV and GI microbiome, worked with HEC
(Sunshine Lake Pharma Co.), Theravectys, and
ThirdLaw, 25 years of experience
JAMES KIRWIN
COO, EXECutive FOUNDER
MBA, Operations; University of Delaware; BS Micro and Molecular Biology, Pensylvania State University
Head of development operations. Big pharma expereince leading global clinical operations at Wyeth/Pfizer, Project Lead AstraZeneca. Led Developement Operations at multilple startups, Arvinas, Iterum Therapeutics, Intercept Pharmaceuticals. Intrexon
Shawn O’BrienChairman
, Western University
Serial life sciences entrepreneur; Founder, Consultant, C-Suite and Board positions at multiple startups including: Genomind, Cipher Pharmaceuticals, Melanovus Oncology, Cyrano Nasal Sciences Altherx, Solstice Neurosciences; and Executive positions at AstraZeneca
robert dickey
CfO
MBA, The Wharton School, University of Pennsylvania, BA Economics, Princeton University.
Board Member, Advisor, C-Level Life Science and Investment Banking Executive. Biotechnology Startup Veteran; South Rampart Pharma, Virtuviae, BCI Life Sciences, Sharp Edge Labs, Emmaus Life Sciences, Sanuthera, Tyme Technolgies, BeyondSpring, Pharmaceuticals, Motif Bio, Neostem, Hemispherx Biopharma, StemCyte, Locus Pharmaceuticals. Investment Banker; Legg Mason, Lehman Brothers
STEFAN WEISS, MDCMO
Expert in the Field of Dermatology, secured multiple new drug approvals. Previously Managing Director of Immunology focused AI data analytics company OM1; Experience in dermatology Real World Evidence research including development of the 10,000 patient ClinPro-DERM study protocol. Fellow of the American Academy of Dermatology and practicing Dermatologist
